Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey
| dc.contributor.author | Yereli K. | |
| dc.contributor.author | Balcioĝlu I.C. | |
| dc.contributor.author | Ertan P. | |
| dc.contributor.author | Limoncu E. | |
| dc.contributor.author | Onaĝ A. | |
| dc.date.accessioned | 2025-04-10T11:17:39Z | |
| dc.date.available | 2025-04-10T11:17:39Z | |
| dc.date.issued | 2004 | |
| dc.description.abstract | The efficacy of albendazole for the treatment of giardiasis has been indicated by previous in-vitro and in-vivo studies. In order to compare the therapeutic efficacy of albendazole and metronidazole, 107 Giardia-positive children (aged 3-15 years), diagnosed by three consecutive positive stool examinations, were enrolled in the study. Of these children, 52 were given a single daily dose of albendazole 10 mg/kg for 5 days, and 55 were given metronidazole 20 mg/kg daily in three doses for 7 days. Parasite eradication was achieved in 47 (90.4%) of 52 children treated with albendazole and 49 (89.1%) of 55 children treated with metronidazole (p > 0.05). These results suggest that albendazole is an effective treatment option for childhood giardiasis. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases. | |
| dc.identifier.DOI-ID | 10.1111/j.1198-743X.2004.00829.x | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/52801 | |
| dc.publisher | Blackwell Publishing Ltd | |
| dc.title | Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey | |
| dc.type | Article |